The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Caitlin Clark mobbed by fans at introductory Indiana Fever press conference
Alexei Navalny death: Team accuses Russia of 'hiding' his body
Coalition government falling short on mosque attack anniversary
EDITORIAL: Top court ruling a step toward allowing same
Caitlin Clark and Angel Reese are OVERPAID at $75k
NZ aid worker Andrew Bagshaw's parents want death in Ukraine recognised as war crime
Coalition government falling short on mosque attack anniversary
Chocolate: Cocoa price hits record high as El Niño hurts crops
Workers at Mercedes factories near Tuscaloosa, Alabama, to vote in May on United Auto Workers union
Fire at industrial building in Ōtaki